of metformin in plasma. The assay enables the measurement of metformin for therapeutic
drug monitoring with a minimum detectable limit of 20 ng/ml. The method involves simple,
one-step extraction procedure and analytical recovery was complete. The separation was
performed on an analytical 150× 4.6 mm id μbondapak C18 column. The wavelength was
set at 235 nm. The mobile phase was 40% acetonitrile, 0.01 M sodium dodecyl sulphate …